Q4 2016 Holdings
Filed 2017-01-18 | 7 holdings | $102.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $33.0M | 1,806,832 | 32.1% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $18.5M | 2,215,384 | 18.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $18.1M | 407,416 | 17.6% |
| Achaogen, Inc. | Common Stock | 004449104 | $16.7M | 1,281,152 | 16.2% |
| ImmuneDesign Corp. | Common Stock | 45252L103 | $12.1M | 2,208,210 | 11.8% |
| Glaukos Corporation(GKOS) | Common Stock | 377322102 | $2.4M | 71,428 | 2.4% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $1.8M | 1,048,601 | 1.8% |